ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Metagenomi Inc

Metagenomi Inc (MGX)

2,52
0,04
( 1,61% )
Aktualisiert: 17:19:58

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
2,52
Gebot
2,52
Fragen
2,54
Volumen
169.725
2,44 Tagesbereich 2,54
1,61 52-Wochen-Bereich 12,74
Marktkapitalisierung
Handelsende
2,48
Handelsbeginn
2,47
Letzte Trade
20
@
2.5201
Letzter Handelszeitpunkt
17:19:51
Finanzvolumen
US$ 422.983
VWAP
2,4922
Durchschnittliches Volumen (3 Mio.)
2.557.284
Ausgegebene Aktien
37.423.917
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-1,35
Gewinn pro Aktie (EPS)
-1,82
Erlöse
44,76M
Nettogewinn
-68,26M

Über Metagenomi Inc

At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of geno... At Metageno-mi, we are cre-at-ing poten-tial-ly cura-tive ther-a-peu-tics using our metage--nomics-pow-ered genome edit-ing toolbox.We believe tools with capa-bil-i-ties that go beyond the cur-rent tech-nol-o-gy land-scape will be required in order to reach the full ther-a-peu-tic poten-tial of genome edit-ing. By har-ness-ing the pow-er of metage-nomics, the study of genomes recov-ered from uncul-ti-vat-ed organ-isms in the nat-ur-al envi-ron-ment, we are dis-cov-er-ing and devel-op-ing a suite of nov-el genome edit-ing tools with the poten-tial to make any desired ther-a-peu-tic gene edit, any-where in the human genome. Mehr anzeigen

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Metagenomi Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MGX. The last closing price for Metagenomi was US$2,48. Over the last year, Metagenomi shares have traded in a share price range of US$ 1,61 to US$ 12,74.

Metagenomi currently has 37.423.917 shares in issue. The market capitalisation of Metagenomi is US$92,81 million. Metagenomi has a price to earnings ratio (PE ratio) of -1.35.

MGX Neueste Nachrichten

Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones

MGX-001 in Hemophilia A Advances Towards US and Ex-US Regulatory Interactions in 2025 NHP Proof-of-Concept Anticipated for Secreted Protein Deficiency Platform in 2025 Leveraging MGX-001 Editing...

Metagenomi Announces New Appointment to its Board of Directors

EMERYVILLE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its...

Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference

EMERYVILLE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its...

Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”

MGX-001, utilizing a highly specific and efficient MG29-1 nuclease, exhibits no identifiable off-target editing MG29-1 nuclease targeting the albumin safe harbor locus showed no evidence of...

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

Therapeutically relevant levels of Factor VIII (FVIII) activity sustained in ongoing nonhuman primate (NHP) study through more than sixteen months of follow up MGX-001 bioengineered FVIII...

The Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGX

The Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGX PR Newswire NEW YORK, Nov. 22, 2024 NEW YORK, Nov. 22, 2024 /PRNewswire/ -- The Gross...

November 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGX

November 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGX PR Newswire NEW YORK, Nov. 21, 2024 NEW YORK, Nov. 21, 2024 /PRNewswire/ -- The Gross Law Firm issues...

Investors who lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX

Investors who lost money on Metagenomi, Inc.(MGX) should contact The Gross Law Firm about pending Class Action - MGX PR Newswire NEW YORK, Nov. 18, 2024 NEW YORK, Nov. 18, 2024 /PRNewswire/...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.04-1.56252.562.862.43315909112.57691526CS
4-0.53-17.37704918033.0542.433117185452.87544115CS
120.6937.70491803281.834.921.6125572843.66014749CS
26-0.57-18.44660194173.094.921.6112724203.49014978CS
52-8.42-76.965265082310.9412.741.616935353.93195786CS
156-7.73-75.414634146310.2512.741.616966323.98580978CS
260-7.73-75.414634146310.2512.741.616966323.98580978CS

MGX - Frequently Asked Questions (FAQ)

What is the current Metagenomi share price?
The current share price of Metagenomi is US$ 2,52
How many Metagenomi shares are in issue?
Metagenomi has 37.423.917 shares in issue
What is the market cap of Metagenomi?
The market capitalisation of Metagenomi is USD 92,81M
What is the 1 year trading range for Metagenomi share price?
Metagenomi has traded in the range of US$ 1,61 to US$ 12,74 during the past year
What is the PE ratio of Metagenomi?
The price to earnings ratio of Metagenomi is -1,35
What is the cash to sales ratio of Metagenomi?
The cash to sales ratio of Metagenomi is 2,07
What is the reporting currency for Metagenomi?
Metagenomi reports financial results in USD
What is the latest annual turnover for Metagenomi?
The latest annual turnover of Metagenomi is USD 44,76M
What is the latest annual profit for Metagenomi?
The latest annual profit of Metagenomi is USD -68,26M
What is the registered address of Metagenomi?
The registered address for Metagenomi is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Metagenomi website address?
The website address for Metagenomi is www.metagenomi.co
Which industry sector does Metagenomi operate in?
Metagenomi operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CYNCYNGN Inc
US$ 0,124
(105,98%)
767,37M
MGOLMGO Global Inc
US$ 0,737801
(77,78%)
332,92M
BDRXBiodexa Pharmaceuticals PLC
US$ 6,51
(59,95%)
18,63M
DOMHDominari Holdings Inc
US$ 4,855
(50,78%)
11,58M
BNAIBrand Engagement Network Inc
US$ 0,608
(48,29%)
182,78M
PLRXPliant Therapeutics Inc
US$ 3,085
(-60,40%)
10,26M
GSIWGarden Stage Ltd
US$ 0,54
(-31,48%)
3,08M
SMTCSemtech Corp
US$ 37,475
(-31,25%)
9,48M
LTRYLottery com Inc
US$ 1,1001
(-31,24%)
5,06M
ATPCAgape ATP Corporation
US$ 0,9265
(-27,05%)
271,79k
CYNCYNGN Inc
US$ 0,124
(105,98%)
767,37M
OCEAOcean Biomedical Inc
US$ 0,125
(-5,94%)
377,74M
MGOLMGO Global Inc
US$ 0,737801
(77,78%)
332,92M
BNAIBrand Engagement Network Inc
US$ 0,608
(48,29%)
182,78M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0766
(41,85%)
161,8M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock